Comment Period Extended to 3/23/2015 for Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials
144 studies found for:    "Parkes Weber syndrome" OR "Vascular Malformations"
Show Display Options
Rank Status Study
21 Completed Efficacy and Safety of Bevacizumab for the Treatment Hemorrhagic Hereditary Telangiectasia (HHT) Associated With Severe Hepatic Vascular Malformations. Phase II Study
Condition: Hemorrhagic Hereditary Telangiectasia
Intervention: Drug: Bevacizumab
22 Active, not recruiting Genetic Basis of Hemangiomas
Condition: Hemangioma, Vascular Anomalies
Interventions: Genetic: Cheek cell samples or blood sample (4mL);   Genetic: Cheek cell sample or blood sample (4mL)
23 Completed Phase I Drug Trial for S/E of Marimastat in Disabling Malformations When no Other Options.
Condition: Vascular Anomalies
Intervention: Drug: Marimastat
24 Recruiting Topical Anti-angiogenic Therapy for Telangiectasia in HHT: Proof of Concept
Condition: Hereditary Hemorrhagic Telangiectasia (HHT).
Interventions: Drug: Topical timolol maleate;   Drug: placebo saline drops
25 Recruiting Treatment of Brain AVMs (TOBAS) Study
Conditions: Unruptured Brain Arteriovenous Malformation;   Ruptured Brain Arteriovenous Malformation;   Arteriovenous Malformations;   AVM;   BAVM
Interventions: Procedure: Neurosurgery;   Radiation: Radiation therapy;   Procedure: Embolization
26 Completed Tranexamic Acid and Epistaxis in Hereditary Hemorrhagic Telangiectasia (HHT)
Condition: Hereditary Hemorrhagic Telangiectasia
Interventions: Drug: Tranexamic acid first, than placebo;   Drug: First placebo, than Tranexamic acid.
27 Unknown  Assessing the Effects of Air-cooling on Capillary Malformations
Conditions: Capillary Malformation;   Laser;   Skin Cooling
Intervention: Device: Air cooling to CM site
28 Recruiting Effect of Laser Treatment on Capillary Malformations
Conditions: Capillary Malformation;   Port Wine Stain
Intervention:
29 Recruiting Functional Magnetic Resonance Imagine(fMRI)Navigation in Intracranial Arteriovenous Malformation Surgery
Condition: Intracranial Arteriovenous Malformations
Interventions: Procedure: fMRI Navigation AVM resection;   Procedure: conventional resection
30 Recruiting Nationwide Treatment Survey of Intracranial Arteriovenous Malformation in China
Condition: Intracranial Arteriovenous Malformations
Intervention:
31 Recruiting ONYX Evaluation in the Endovascular Treatment of Cerebral Arteriovenous Malformations (cAVM)
Condition: Cerebral Arteriovenous Malformations
Intervention:
32 Unknown  Permeability MRI in Cerebral Cavernous Malformations Type 1 in New Mexico: Effects of Statins
Conditions: Cavernous Angioma, Familial;   Cerebral Cavernous Malformations;   Cerebral Cavernous Hemangioma
Intervention: Drug: Simvastatin
33 Recruiting MRI for the Early Evaluation of Acute Intracerebral Hemorrhage
Conditions: Cerebral Hemorrhage;   Intracranial Arteriovenous Malformations;   Intracranial Hemorrhage, Hypertensive;   Brain Neoplasms
Intervention: Device: MRI Scan with the specified sequences below:
34 Unknown  Modifiers of Disease Severity in Cerebral Cavernous Malformations
Conditions: Cavernous Angioma, Familial;   Cerebral Cavernous Malformations;   Cerebral Cavernous Hemangioma
Intervention: Other: Natural history data collection
35 Completed Tetracycline-Derivatives for Treatment of Cerebral Arteriovenous Malformations and Aneurysms
Conditions: Aneurysms;   Arteriovenous Malformations
Interventions: Drug: minocycline;   Drug: doxycycline
36 Completed A Study of PRT-201 Administered Immediately After Arteriovenous Fistula Creation in Patients With Chronic Kidney Disease
Condition: Chronic Kidney Disease
Interventions: Drug: PRT-201;   Drug: Placebo
37 Completed A Multicenter, Open-label Study for E7040 in Japanese Subjects With Hypervascular Tumor and Subjects With Arteriovenous Malformation
Condition: Hypervascular Tumor and Arteriovenous Malformation
Intervention: Device: E7040
38 Unknown  Efficacy of Thalidomide in the Treatment of Hereditary Hemorrhagic Telangiectasia
Conditions: Hereditary Hemorrhagic Telangiectasia;   Epistaxis
Intervention: Drug: Thalidomide
39 Completed
Has Results
Vitamin D and Arteriovenous Fistulae
Condition: End-stage Renal Disease
Interventions: Drug: Vitamin D3;   Drug: Placebo
40 Terminated Review of Descending Aortic Flow Reversal in Total Anomalous Pulmonary Venous Connection
Condition: Congenital Disorders
Intervention:

First Page    Show previous page of results Previous Page (1-20) Studies Shown (21-40) Next Page (41-60) Show next page of results    Last Page
Indicates status has not been verified in more than two years